GENB
Generate Biomedicines, Inc. Common StockKey Statistics
About Generate Biomedicines, Inc. Common Stock
Generate Biomedicines, Inc. is an innovative biotechnology company focused on harnessing the power of genetic engineering to develop protein therapeutics for a range of diseases. By leveraging advanced artificial intelligence and machine learning technologies, Generate Biomedicines aims to streamline the drug discovery process, significantly reducing time and costs associated with traditional methods. The company's proprietary platform enables the rapid design and optimization of therapeutic proteins, positioning it at the forefront of the biopharmaceutical industry. With a strong commitment to improving patient outcomes, Generate Biomedicines continues to expand its pipeline and collaborate with leading partners to bring transformative treatments to market.
Fundamentals
| Revenue (TTM) | $31.89M |
| Gross Profit (TTM) | $-192.80M |
| EBITDA | $-221.89M |
| Operating Margin | -737.00% |
| Return on Equity | -81.70% |
| Return on Assets | -34.60% |
| Revenue/Share (TTM) | $0.64 |
| Book Value | $-12.24 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 57.78 |
| EV/Revenue | 47.75 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $127.45M |
| Float | $48.25M |
| % Insiders | 22.62% |
| % Institutions | 0.71% |